Risk Factors for Recurrence after Resection of Hepatitis C Virus-related Hepatocellular Carcinoma

被引:0
|
作者
Shoji Kubo
Kazuhiro Hirohashi
Hiromu Tanaka
Tadashi Tsukamoto
Taichi Shuto
Takashi Ikebe
Takatsugu Yamamoto
Kenichi Wakasa
Shuhei Nishiguchi
Tetsuo Kuroki
Hiroaki Kinoshita
机构
[1] Second Department of Surgery,
[2] Osaka City University Medical School,undefined
[3] 1-4-3 Asahimachi,undefined
[4] Abeno-ku,undefined
[5] Osaka 545-8585,undefined
[6] Japan,undefined
[7] Second Department of Pathology,undefined
[8] Osaka City University Medical School,undefined
[9] 1-4-3 Asahimachi,undefined
[10] Abeno-ku,undefined
[11] Osaka 545-8585,undefined
[12] Japan,undefined
[13] Department of Pathology,undefined
[14] Osaka City University Hospital,undefined
[15] 1-5-3 Asahimachi,undefined
[16] Abeno-ku,undefined
[17] Osaka 545-8586,undefined
[18] Japan,undefined
[19] Third Department of Internal Medicine,undefined
[20] Osaka City University Medical School,undefined
[21] 1-4-3 Asahimachi,undefined
[22] Abeno-ku,undefined
[23] Osaka 545-8585,undefined
[24] Japan,undefined
来源
World Journal of Surgery | 2000年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although there have been many studies of the risk factors for recurrence after resection of hepatocellular carcinoma (HCC), the subjects were patients with various viral status in the previous studies, and hepatitis C viremia has not been evaluated. We investigated risk factors, including hepatic C viremia and histologic findings of noncancerous hepatic tissue, for recurrence after resection of hepatitis C virus (HCV)-related HCC. A total of 223 patients who underwent liver resection for HCV-related HCC were studied. HCV viremia, laboratory data, degree of HCC malignancy, histologic findings in noncancerous hepatic tissue, preoperative interferon therapy, and operative methods were evaluated for recurrence risk by univariate and multivariate analyses. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin, and the proportion of patients with a high histologic activity score (mild to severe active hepatitis) were significantly higher in patients with HCV viremia than in those without viremia. Serum albumin was significantly lower in patients with HCV viremia. By univariate analysis, older age (> 65 years old), HCV viremia, elevated AST (> 40 IU/L) and ALT (> 45 IU/L), large tumors (> 40 mm), multiple HCCs, moderately or poorly differentiated HCC, portal invasion, mild to severe active hepatitis, and lack of preoperative interferon therapy were risk factors for recurrence. Multivariate analysis showed that older age, HCV viremia, high AST, multiple HCCs, and portal invasion were independent risk factors. For HCV-related HCCs, not only the degree of maliganacy of the HCC but also HCV viremia and active hepatitis are risk factors for recurrence.
引用
收藏
页码:1559 / 1565
页数:6
相关论文
共 50 条
  • [1] Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma
    Kubo, S
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Shuto, T
    Ikebe, T
    Yamamoto, T
    Wakasa, K
    Nishiguchi, S
    Kuroki, T
    Kinoshita, H
    WORLD JOURNAL OF SURGERY, 2000, 24 (12) : 1559 - 1565
  • [2] Influence of previous interferon therapy on recurrence after resection of hepatitis C virus-related hepatocellular carcinoma
    Kubo, S
    Nishiguchi, S
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Shuto, T
    Takemura, S
    Yamamoto, T
    Ikebe, T
    Wakasa, K
    Shiomi, S
    Kinoshita, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (01): : 59 - 66
  • [3] Influence of preoperative interferon therapy on recurrence after resection of hepatitis C virus-related hepatocellular carcinoma.
    Kubo, S
    Nishiguchi, S
    Tamori, A
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Shuto, T
    Ikebe, T
    Yamamoto, T
    Wakasa, K
    Kuroki, T
    Kinoshita, H
    HEPATOLOGY, 1999, 30 (04) : 684A - 684A
  • [4] Effect of interferon therapy on first and second recurrence after resection of hepatitis C virus-related hepatocellular carcinoma
    Sakae, Masayuki
    Kubo, Shoji
    Takemura, Shigekazu
    Sakata, Chikaharu
    Uenishi, Takahiro
    Kodai, Shintaro
    Shinkawa, Hiroji
    Urata, Yorihisa
    Ohata, Kazunori
    Kaneda, Kazuhisa
    Nishioka, Takayoshi
    Nozawa, Akinori
    Suehiro, Shigefumi
    HEPATOLOGY RESEARCH, 2012, 42 (06) : 564 - 573
  • [5] Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma
    Uenishi, Takahiro
    Nishiguchi, Shuhei
    Tanaka, Shogo
    Yamamoto, Takatsugu
    Takemura, Shigekazu
    Kubo, Shoji
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (05) : 358 - 362
  • [6] The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus-related hepatocellular carcinoma
    Kaneda, Kazuhisa
    Uenishi, Takahiro
    Takemura, Shigekazu
    Shinkawa, Hiroji
    Urata, Yorihisa
    Sakae, Masayuki
    Yamamoto, Takatsugu
    Kubo, Shoji
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (06) : 606 - 611
  • [7] Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
    Choi, Jonggi
    Jo, Chanyoung
    Lim, Young-Suk
    HEPATOLOGY, 2021, 73 (02) : 661 - 673
  • [8] Tenofovir is superior to entecavir on recurrence in hepatitis B virus-related hepatocellular carcinoma after curative resection
    Tsai, Ming-Chao
    Wang, Chih-Chi
    Lee, Wei-Chen
    Liu, Yueh-Wei
    Lin, Chih-Che
    Hu, Tsung-Hui
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 163 - 163
  • [9] Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
    Yoo, Sun
    Kim, Ji Yoon
    Lim, Young-Suk
    Han, Seungbong
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 939 - 946
  • [10] Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma
    Kubo, S
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Shuto, T
    Yamamoto, T
    Ikebe, T
    Wakasa, K
    Nishiguchi, S
    Kinoshita, H
    CANCER, 2000, 88 (05) : 1016 - 1024